Seeking Alpha
 

Nektar Therapeutics (NKTR)

- NASDAQ
  • InvestingInsights | Send Message 29 Jun

    $ISIS $NKTR $CRIS Biotech Jumps and Slumps: ISIS Pharmaceuticals, Inc., Nektar Therapeutics, Curis, Inc. http://tinyurl.com/npymjpb
    Reply
      • Investors Prophet | Send Message 25 Jun

        BUY ALERTS (NASDAQ Strategy) ... $NKTR ... Prices for recent alerts: http://ow.ly/OLLt9
        Reply
          • wazzaofwallst | Send Message 23 Jun

            With an ROE of 77.4% $NKTR is cranking. What about the rest? http://bit.ly/1Ixvr7V
            Reply
              • InvestingInsights | Send Message 18 Jun

                $NKTR Roth Capital Pounds the Table on Nektar Therapeutics http://bit.ly/1K0E0MO
                Reply
                  • Stephen Simpson, CFA | Send Message 21 May

                    With Nektar Therapeutics, Value Never Comes Easy $NKTR http://seekingalpha.com/a/1wkvc
                    Reply
                      • Harish Mano | Send Message 2 May

                        $nktr upbeat or false alarm what are we looking at?
                        Reply (2)
                        • BiotechX | Send Message 3 May
                          : We look at excellent Q1 results - not more not less.
                        • BiotechX | Send Message 23 May
                          : The last SA article "With Nektar Therapeutics, Value Never Comes Easy " from May, 20, describes the situation quite well.
                          • Scrying Biotech | Send Message 23 Mar

                            Nektar-102 Will Be An Approved Treatment In Metastatic Breast Cancer $NKTR http://seekingalpha.com/a/1sqh4
                            Reply
                              • Investors Prophet | Send Message 19 Mar

                                SELL ALERTS (NASDAQ Strategy) ... $NKTR ... Prices for recent alerts: http://ow.ly/KwFWo
                                Reply
                                  • BiotechX | Send Message 18 Mar

                                    I believe market cap for $NKTR makes still sense based on recently approved MOVANTIK in USA/EU and successfulk PhIII of BAX855.
                                    Reply (1)
                                    • BiotechX | Send Message 18 Mar
                                      : The market was not too optimistic for this difficult to treat patient group - subgroup analysis looks promissing!
                                      • pat45 | Send Message 18 Mar

                                        $NKTR drug failed, big market cap and needs money = short? Will watch tape but could fall big tīme.
                                        Reply
                                          Visit Seeking Alpha's
                                          NKTR vs. ETF Alternatives
                                          Company Description
                                          Nektar Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company develops a pipeline of drug candidates that utilizes its PEGylation and polymer conjugate technology platforms that are designed to developmolecular entities.
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States